{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:37:41Z","timestamp":1786113461431,"version":"build-2736575974"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,26]],"date-time":"2027-06-26T00:00:00Z","timestamp":1813968000000},"content-version":"am","delay-in-days":298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020091","name":"Propionic Acidemia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["R21 TR005163"],"award-info":[{"award-number":["R21 TR005163"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118187","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:14:34Z","timestamp":1782317674000},"page":"118187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Precision metabolic therapy for propionic acidemia"],"prefix":"10.1016","volume":"251","author":[{"given":"Boopathi","family":"Subramaniyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chorlada","family":"Paiboonrungruang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118187_b0005","first-page":"22","article-title":"Spectrum of mutations underlying Propionic acidemia and further insight into a genotype-phenotype correlation for the common mutation in Saudi Arabia","volume":"18","author":"Al-Hamed","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.bcp.2026.118187_b0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ymgme.2004.08.001","article-title":"Propionic acidemia: mutation update and functional and structural effects of the variant alleles","volume":"83","author":"Desviat","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0015","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1203\/00006450-197906000-00005","article-title":"Human propionyl CoA carboxylase: some properties of the partially purified enzyme in fibroblasts from controls and patients with propionic acidemia","volume":"13","author":"Hsia","year":"1979","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bcp.2026.118187_b0020","unstructured":"Carlina GA, Shchelochkov OA, Serrano TJ, et al. Propionic Acidemia. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, eds. GeneReviews((R)). Seattle (WA), 2024."},{"key":"10.1016\/j.bcp.2026.118187_b0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ymgme.2018.09.008","article-title":"Identification of 34 novel mutations in propionic acidemia: functional characterization of missense variants and phenotype associations","volume":"125","author":"Rivera-Barahona","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11306-023-01975-2","article-title":"Ischemia promotes acyl-CoAs dephosphorylation and propionyl-CoA accumulation","volume":"19","author":"He","year":"2023","journal-title":"Metabolomics"},{"key":"10.1016\/j.bcp.2026.118187_b0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2021.09.009","article-title":"Metabolic perturbations mediated by propionyl-CoA accumulation in organs of mouse model of propionic acidemia","volume":"134","author":"He","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0040","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0026-0495(90)90084-P","article-title":"Sources of propionate in inborn errors of propionate metabolism","volume":"39","author":"Thompson","year":"1990","journal-title":"Metabolism"},{"key":"10.1016\/j.bcp.2026.118187_b0045","first-page":"279","article-title":"Molecular cloning of rat acss3 and characterization of mammalian propionyl-CoA synthetase in the liver mitochondrial matrix","volume":"161","author":"Yoshimura","year":"2017","journal-title":"J. Biochem."},{"key":"10.1016\/j.bcp.2026.118187_b0050","doi-asserted-by":"crossref","first-page":"e665","DOI":"10.1002\/ctm2.665","article-title":"ACSS3 in brown fat drives propionate catabolism and its deficiency leads to autophagy and systemic metabolic dysfunction","volume":"12","author":"Jia","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118187_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108501","article-title":"Pathophysiological mechanisms of complications associated with propionic acidemia","volume":"249","author":"Marchuk","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2026.118187_b0060","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-3476(81)80004-2","article-title":"Propionic acidemia: a clinical update","volume":"99","author":"Wolf","year":"1981","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bcp.2026.118187_b0065","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s10545-015-9839-3","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation","volume":"38","author":"Kolker","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2025.1499376","article-title":"Elevated propionate and its association with neurological dysfunctions in propionic acidemia","volume":"18","author":"Chen","year":"2025","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2026.118187_b0075","first-page":"1","article-title":"The re-occurrence of dilated cardiomyopathy in propionic acidemia after liver transplantation requiring heart transplant, first case from Middle East","author":"Hejazi","year":"2022","journal-title":"Cardiol. Young"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2026.118187_b0080","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1007\/s10545-009-1029-8","article-title":"Extracorporeal membrane oxygenation in a patient with propionic acidaemia: a therapeutic option for cardiac failure","volume":"32","author":"Mizuguchi","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165682","article-title":"Disturbance of bioenergetics and calcium homeostasis provoked by metabolites accumulating in propionic acidemia in heart mitochondria of developing rats","volume":"1866","author":"Roginski","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0090","doi-asserted-by":"crossref","first-page":"E622","DOI":"10.1152\/ajpendo.00081.2018","article-title":"Propionate-induced changes in cardiac metabolism, notably CoA trapping, are not altered by l-carnitine","volume":"315","author":"Wang","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00018-025-05661-5","article-title":"Metabolic flux analysis in hiPSC-CMs reveals insights into cardiac dysfunction in propionic acidemia","volume":"82","author":"Richard","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2026.118187_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2016.04.007","article-title":"In vivo evidence of mitochondrial dysfunction and altered redox homeostasis in a genetic mouse model of propionic acidemia: implications for the pathophysiology of this disorder","volume":"96","author":"Gallego-Villar","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.118187_b0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1203\/PDR.0b013e3181a7c270","article-title":"Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria","volume":"66","author":"de Keyzer","year":"2009","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bcp.2026.118187_b0110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1620\/tjem.137.329","article-title":"Comparison of cytosolic and mitochondrial enzyme alterations in the livers of propionic or methylmalonic acidemia: a reduction of cytochrome oxidase activity","volume":"137","author":"Hayasaka","year":"1982","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.bcp.2026.118187_b0115","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1067\/mpd.2000.104290","article-title":"Resting energy expenditure in disorders of propionate metabolism","volume":"136","author":"Feillet","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bcp.2026.118187_b0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10545-017-0111-x","article-title":"Propionyl-CoA carboxylase pcca-1 and pccb-1 gene deletions in Caenorhabditis elegans globally impair mitochondrial energy metabolism","volume":"41","author":"Chapman","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0125","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10545-012-9545-3","article-title":"Functional characterization of novel genotypes and cellular oxidative stress studies in propionic acidemia","volume":"36","author":"Gallego-Villar","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymgme.2009.06.007","article-title":"Profiling of oxidative stress in patients with inborn errors of metabolism","volume":"98","author":"Mc Guire","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0135","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1111\/j.1651-2227.2012.02799.x","article-title":"Patients with organic acidaemias have an altered thiol status","volume":"101","author":"Salmi","year":"2012","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.bcp.2026.118187_b0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bbrc.2014.08.091","article-title":"Antioxidants successfully reduce ROS production in propionic acidemia fibroblasts","volume":"452","author":"Gallego-Villar","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2026.118187_b0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ymgme.2017.07.009","article-title":"Treatment with antioxidants ameliorates oxidative damage in a mouse model of propionic acidemia","volume":"122","author":"Rivera-Barahona","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijns7030035","article-title":"Current perspectives on neonatal screening for propionic acidemia in Japan: an unexpectedly high incidence of patients with mild disease caused by a common PCCB variant","volume":"7","author":"Tajima","year":"2021","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.bcp.2026.118187_b0155","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.hrthm.2016.02.003","article-title":"Mechanisms of acquired long QT syndrome in patients with propionic academia","volume":"13","author":"Bodi","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.bcp.2026.118187_b0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13023-017-0585-5","article-title":"Possible mechanisms for sensorineural hearing loss and deafness in patients with propionic acidemia","volume":"12","author":"Grunert","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0165","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.mito.2011.02.002","article-title":"Fatal heart failure associated with CoQ10 and multiple OXPHOS deficiency in a child with propionic acidemia","volume":"11","author":"Fragaki","year":"2011","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bcp.2026.118187_b0170","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.mito.2014.07.001","article-title":"Successful reversal of propionic acidaemia associated cardiomyopathy: evidence for low myocardial coenzyme Q10 status and secondary mitochondrial dysfunction as an underlying pathophysiological mechanism","volume":"17","author":"Baruteau","year":"2014","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bcp.2026.118187_b0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ymgme.2005.04.004","article-title":"Clinical, pathological, and biochemical studies in a patient with propionic acidemia and fatal cardiomyopathy","volume":"85","author":"Mardach","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0180","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-3476(96)70162-2","article-title":"Primary treatment of propionic acidemia complicated by acute thiamine deficiency","volume":"129","author":"Matern","year":"1996","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bcp.2026.118187_b0185","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0885-4505(86)90097-6","article-title":"Methylmalonic and propionic acidemias: lipid profiles of normal and affected human skin fibroblasts incubated with [1-14C]propionate","volume":"35","author":"Giudici","year":"1986","journal-title":"Biochem. Med. Metab. Biol."},{"key":"10.1016\/j.bcp.2026.118187_b0190","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41467-017-01384-9","article-title":"Characterization of histone acylations links chromatin modifications with metabolism","volume":"8","author":"Simithy","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118187_b0195","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72171","article-title":"Short-chain fatty acids activate acetyltransferase p300","volume":"10","author":"Thomas","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2026.118187_b0200","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jnutbio.2007.08.002","article-title":"Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon","volume":"19","author":"Waldecker","year":"2008","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bcp.2026.118187_b0205","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/jimd.12296","article-title":"Increased protein propionylation contributes to mitochondrial dysfunction in liver cells and fibroblasts, but not in myotubes","volume":"44","author":"Lagerwaard","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0210","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/nsmb.3490","article-title":"Histone propionylation is a mark of active chromatin","volume":"24","author":"Kebede","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2026.118187_b0215","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-024-07471-4","article-title":"Nuclear position and local acetyl-CoA production regulate chromatin state","volume":"630","author":"Willnow","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118187_b0220","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrm.2016.140","article-title":"Metabolic regulation of gene expression through histone acylations","volume":"18","author":"Sabari","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118187_b0225","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2016.06.038","article-title":"Diverse activities of histone acylations connect metabolism to chromatin function","volume":"63","author":"Dutta","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2026.118187_b0230","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/s44161-023-00365-0","article-title":"Disrupted propionate metabolism evokes transcriptional changes in the heart by increasing histone acetylation and propionylation","volume":"2","author":"Park","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2026.118187_b0235","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ymgme.2015.05.004","article-title":"Gene expression in cell lines from propionic acidemia patients, carrier parents, and controls","volume":"115","author":"Chapman","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0240","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169399","article-title":"Reducing branched-chain amino acids improves cardiac stress response in mice by decreasing histone H3K23 propionylation","volume":"133","author":"Yang","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"2228\u20132244","key":"10.1016\/j.bcp.2026.118187_b0245","first-page":"e7","article-title":"Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11","volume":"36","author":"Zhou","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2011.09.026","article-title":"Acute management of propionic acidemia","volume":"105","author":"Chapman","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0255","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10528-014-9657-6","article-title":"Two frequent mutations associated with the classic form of propionic acidemia in Taiwan","volume":"52","author":"Chiu","year":"2014","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.bcp.2026.118187_b0260","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jimd.12570","article-title":"Relief of CoA sequestration and restoration of mitochondrial function in a mouse model of propionic acidemia","volume":"46","author":"Subramanian","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0265","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1590\/0004-2730000002821","article-title":"Emerging trends in management of propionic acidemia","volume":"58","author":"Rafique","year":"2014","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.bcp.2026.118187_b0270","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mrgentox.2010.07.008","article-title":"Prevention by L-carnitine of DNA damage induced by propionic and L-methylmalonic acids in human peripheral leukocytes in vitro","volume":"702","author":"Ribas","year":"2010","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bcp.2026.118187_b0275","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","article-title":"Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia","volume":"9","author":"Baumgartner","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0280","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2011.08.034","article-title":"Chronic management and health supervision of individuals with propionic acidemia","volume":"105","author":"Sutton","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0285","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jpeds.2003.12.044","article-title":"The importance of gut motility in the metabolic control of propionic acidemia","volume":"144","author":"Prasad","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bcp.2026.118187_b0290","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ymgme.2011.04.007","article-title":"45-Year-old female with propionic acidemia, renal failure, and premature ovarian failure; late complications of propionic acidemia?","volume":"103","author":"Lam","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0295","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1212\/WNL.39.10.1343","article-title":"Adult-onset chorea and dementia with propionic acidemia","volume":"39","author":"Sethi","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2026.118187_b0300","first-page":"3","article-title":"The re-occurrence of cardiomyopathy in propionic acidemia after liver transplantation","volume":"54","author":"Berry","year":"2020","journal-title":"JIMD Rep"},{"key":"10.1016\/j.bcp.2026.118187_b0305","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymgme.2012.10.022","article-title":"Improved neurologic prognosis for a patient with propionic acidemia who received early living donor liver transplantation","volume":"108","author":"Nagao","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0310","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1399-3046.2006.00569.x","article-title":"Evaluation and management of patients with propionic acidemia undergoing liver transplantation: a comprehensive review","volume":"10","author":"Barshes","year":"2006","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.bcp.2026.118187_b0315","article-title":"Survival of propionic acidemia patients with liver transplant","volume":"40","author":"Zelei","year":"2024","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.bcp.2026.118187_b0320","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/B:BOLI.0000028778.54210.13","article-title":"Living-donor liver transplantation for propionic acidaemia","volume":"27","author":"Yorifuji","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0325","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13023-019-1045-1","article-title":"Methylmalonic acidemia\/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups","volume":"14","author":"Chu","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0330","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/lt.22279","article-title":"Liver transplantation for propionic acidemia in children","volume":"17","author":"Vara","year":"2011","journal-title":"Liver Transpl."},{"key":"10.1016\/j.bcp.2026.118187_b0335","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1007\/s12325-020-01305-1","article-title":"Post-transplantation outcomes in patients with PA or MMA: a review of the literature","volume":"37","author":"Yap","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.bcp.2026.118187_b0340","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1038\/s41467-024-47460-9","article-title":"Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria","volume":"15","author":"Baek","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118187_b0345","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1038\/s41467-020-19156-3","article-title":"Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia","volume":"11","author":"Jiang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118187_b0350","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/hum.2010.164","article-title":"Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia","volume":"22","author":"Chandler","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bcp.2026.118187_b0355","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mt.2009.247","article-title":"Long-term rescue of a lethal murine model of methylmalonic acidemia using adeno-associated viral gene therapy","volume":"18","author":"Chandler","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2026.118187_b0360","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/hum.2014.126","article-title":"Long-term sex-biased correction of circulating propionic acidemia disease markers by adeno-associated virus vectors","volume":"26","author":"Guenzel","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bcp.2026.118187_b0365","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/hum.2014.012","article-title":"Effects of adeno-associated virus serotype and tissue-specific expression on circulating biomarkers of propionic acidemia","volume":"25","author":"Guenzel","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bcp.2026.118187_b0370","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/mt.2013.68","article-title":"Generation of a hypomorphic model of propionic acidemia amenable to gene therapy testing","volume":"21","author":"Guenzel","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2026.118187_b0375","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/hum.2008.158","article-title":"Short-term rescue of neonatal lethality in a mouse model of propionic acidemia by gene therapy","volume":"20","author":"Hofherr","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bcp.2026.118187_b0380","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s41586-024-07266-7","article-title":"Interim analyses of a first-in-human phase 1\/2 mRNA trial for propionic acidaemia","volume":"628","author":"Koeberl","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118187_b0385","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41587-022-01491-z","article-title":"Unlocking the promise of mRNA therapeutics","volume":"40","author":"Rohner","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcp.2026.118187_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2026.118187_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9050530","article-title":"Non-immunotherapy application of LNP-mRNA: maximizing efficacy and safety","volume":"9","author":"Vlatkovic","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bcp.2026.118187_b0400","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adq0143","article-title":"Inhibition of CXCL10 and IFN-gamma ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA vaccination","volume":"17","author":"Cao","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118187_b0405","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s42255-024-01059-y","article-title":"Coenzyme a biosynthesis: mechanisms of regulation, function and disease","volume":"6","author":"Barritt","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.bcp.2026.118187_b0410","first-page":"1022","article-title":"Cytosolic acetyl-coenzyme a is a signalling metabolite to control mitophagy","author":"Zhang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118187_b0415","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf5965","article-title":"Pantothenate kinase activation relieves coenzyme a sequestration and improves mitochondrial function in mice with propionic acidemia","volume":"13","author":"Subramanian","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2026.118187_b0420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ymgme.2021.03.001","article-title":"A novel small molecule approach for the treatment of propionic and methylmalonic acidemias","volume":"133","author":"Armstrong","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082768","article-title":"Metabolic reprogramming in health and disease","volume":"21","author":"Chiellini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1394\u20131410","key":"10.1016\/j.bcp.2026.118187_b0430","first-page":"e12","article-title":"Imaging brain glucose metabolism in vivo reveals propionate as a major anaplerotic substrate in pyruvate dehydrogenase deficiency","volume":"36","author":"Marin-Valencia","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0435","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2014.11.020","article-title":"Acetate dependence of tumors","volume":"159","author":"Comerford","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118187_b0440","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ccell.2014.12.002","article-title":"Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress","volume":"27","author":"Schug","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.118187_b0445","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature22405","article-title":"Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory","volume":"546","author":"Mews","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118187_b0450","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jcp.24927","article-title":"Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest","volume":"230","author":"Long","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2026.118187_b0455","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/ijc.28465","article-title":"Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma","volume":"134","author":"Tsen","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2026.118187_b0460","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymgme.2011.03.012","article-title":"A safety trial of high dose glyceryl triacetate for Canavan disease","volume":"103","author":"Segel","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0465","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s10545-009-1155-3","article-title":"Glyceryl triacetate for Canavan disease: a low-dose trial in infants and evaluation of a higher dose for toxicity in the tremor rat model","volume":"32","author":"Madhavarao","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0470","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1124\/pharmrev.121.000408","article-title":"Acylcarnitines: nomenclature, biomarkers, therapeutic potential, drug targets, and clinical trials","volume":"74","author":"Dambrova","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2026.118187_b0475","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.cell.2012.02.032","article-title":"Cellular metabolism and disease: what do metabolic outliers teach us?","volume":"148","author":"DeBerardinis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118187_b0480","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10545-006-0320-1","article-title":"Anaplerotic molecules: current and future","volume":"29","author":"Brunengraber","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0485","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymgme.2017.07.003","article-title":"Anaplerotic therapy in propionic acidemia","volume":"122","author":"Longo","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2026.118187_b0490","article-title":"Mitochondrial dysfunction in methylmalonic acidemia: a pilot study using Seahorse technology in peripheral blood","volume":"45","author":"Stanescu","year":"2025","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.bcp.2026.118187_b0495","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2026.118187_b0500","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1074\/jbc.RA118.005963","article-title":"Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus","volume":"294","author":"Fu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118187_b0505","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1042\/BCJ20200452","article-title":"NRF2\/ACSS2 axis mediates the metabolic effect of alcohol drinking on esophageal squamous cell carcinoma","volume":"477","author":"Odera","year":"2020","journal-title":"Biochem. J"},{"key":"10.1016\/j.bcp.2026.118187_b0510","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/gutjnl-2012-303731","article-title":"Nrf2 deficiency impairs the barrier function of mouse oesophageal epithelium","volume":"63","author":"Chen","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2026.118187_b0515","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2022.07.013","article-title":"Nrf2 as a regulator of mitochondrial function: Energy metabolism and beyond","volume":"189","author":"Esteras","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2026.118187_b0520","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3390\/cells11152416","article-title":"NADPH and mitochondrial quality control as targets for a circadian-based fasting and exercise therapy for the treatment of parkinson's disease","volume":"11","author":"Curtis","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118187_b0525","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/carcin\/bgp231","article-title":"Nrf2: friend or foe for chemoprevention?","volume":"31","author":"Kensler","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2026.118187_b0530","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/tx100389r","article-title":"Modification of keap1 cysteine residues by sulforaphane","volume":"24","author":"Hu","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bcp.2026.118187_b0535","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1158\/1940-6207.CAPR-10-0296","article-title":"Bioavailability of Sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China","volume":"4","author":"Egner","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.bcp.2026.118187_b0540","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1158\/1940-6207.CAPR-08-0192","article-title":"Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans","volume":"2","author":"Yanaka","year":"2009","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.bcp.2026.118187_b0545","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/molecules25040829","article-title":"Measuring sulforaphane and its metabolites in human plasma: a high throughput method","volume":"25","author":"Langston-Cox","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.118187_b0550","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1017\/jns.2025.10033","article-title":"Sulforaphane as a potential therapeutic agent: a comprehensive analysis of clinical trials and mechanistic insights","volume":"14","author":"Saito","year":"2025","journal-title":"J Nutr Sci"},{"key":"10.1016\/j.bcp.2026.118187_b0555","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.clnu.2019.03.022","article-title":"The potential use of l-sulforaphane for the treatment of chronic inflammatory diseases: a review of the clinical evidence","volume":"39","author":"Mazarakis","year":"2020","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.bcp.2026.118187_b0560","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3390\/ijms27042028","article-title":"Sulforaphane in cancer prevention and therapy: a state-of-the-art review of epidemiological evidence, molecular mechanisms, and translational challenges","volume":"27","author":"Jang","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118187_b0565","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molmed.2023.12.002","article-title":"Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia","volume":"30","author":"Pilotto","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bcp.2026.118187_b0570","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.3390\/ijms14047853","article-title":"Frataxin deficiency leads to reduced expression and impaired translocation of NF-E2-related factor (Nrf2) in cultured motor neurons","volume":"14","author":"D'Oria","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118187_b0575","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1089\/ars.2012.4537","article-title":"Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model","volume":"19","author":"Shan","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2026.118187_b0580","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in friedreich ataxia (MOXIe study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcp.2026.118187_b0585","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.29286","article-title":"Efficacy of omaveloxolone in friedreich's ataxia: delayed-start analysis of the MOXIe extension","volume":"38","author":"Lynch","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bcp.2026.118187_b0590","unstructured":"Research FCfDEa. Review of natural history study as confirmatory evidence for the efficacy of omaveloxolone for treatment of Friedreich\u2019s ataxia, 2023."},{"key":"10.1016\/j.bcp.2026.118187_b0595","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40120-025-00749-3","article-title":"Safety monitoring of omaveloxolone in friedreich ataxia: results from one year of clinical treatment","volume":"14","author":"Gunther","year":"2025","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.bcp.2026.118187_b0600","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00395-024-01066-w","article-title":"The attenuated hepatic clearance of propionate increases cardiac oxidative stress in propionic acidemia","volume":"119","author":"Wang","year":"2024","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bcp.2026.118187_b0605","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70114","article-title":"Nutritional management in severe methylmalonic and propionic acidemias: how much medical food is too much?","volume":"49","author":"Margoses","year":"2026","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0610","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41467-024-55036-w","article-title":"Pantothenate kinase 4 controls skeletal muscle substrate metabolism","volume":"16","author":"Miranda-Cervantes","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118187_b0615","doi-asserted-by":"crossref","DOI":"10.1126\/science.ads9530","article-title":"Deep contrastive learning enables genome-wide virtual screening","volume":"391","author":"Jia","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118187_b0620","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.14336\/AD.2023.0216-1","article-title":"Pantothenate kinase 4 governs lens epithelial fibrosis by negatively regulating pyruvate kinase M2-related glycolysis","volume":"14","author":"Li","year":"2023","journal-title":"Aging Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0625","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/humu.23696","article-title":"A novel mutation of PANK4 causes autosomal dominant congenital posterior cataract","volume":"40","author":"Sun","year":"2019","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcp.2026.118187_b0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192028","article-title":"Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models","volume":"13","author":"Elbaum","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118187_b0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103914","article-title":"N-acetyl-l-cysteine ethyl ester (NACET) induces the transcription factor NRF2 and prevents retinal aging and diabetic retinopathy","volume":"88","author":"Realini","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2026.118187_b0640","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.bcp.2012.09.010","article-title":"N-Acetylcysteine ethyl ester (NACET): a novel lipophilic cell-permeable cysteine derivative with an unusual pharmacokinetic feature and remarkable antioxidant potential","volume":"84","author":"Giustarini","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118187_b0645","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jimd.12128","article-title":"Pathophysiology of propionic and methylmalonic acidemias. Part 2: Treatment strategies","volume":"42","author":"Haijes","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102848","article-title":"Carnitine octanoyltransferase is important for the assimilation of exogenous acetyl-L-carnitine into acetyl-CoA in mammalian cells","volume":"299","author":"Hsu","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118187_b0655","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.930250","article-title":"Connecting metabolic rewiring with phenotype switching in melanoma","volume":"10","author":"Falletta","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2026.118187_b0660","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/febs.15853","article-title":"Metabolic rewiring: a new master of Th17 cell plasticity and heterogeneity","volume":"289","author":"Papadopoulou","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2026.118187_b0665","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jimd.12478","article-title":"Biomarkers for drug development in propionic and methylmalonic acidemias","volume":"45","author":"Longo","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bcp.2026.118187_b0670","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa2504747","article-title":"Patient-specific in vivo gene editing to treat a rare genetic disease","volume":"392","author":"Musunuru","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2026.118187_b0675","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/CIRCULATIONAHA.125.074218","article-title":"Genomic editing of a pathogenic sequence variant in ACTA2 rescues multisystemic smooth muscle dysfunction syndrome in mice","volume":"152","author":"Ding","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2026.118187_b0680","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41551-025-01499-1","article-title":"Treatment of a severe vascular disease using a bespoke CRISPR-Cas9 base editor in mice","volume":"10","author":"Alves","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bcp.2026.118187_b0685","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41591-026-04254-4","article-title":"In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial","volume":"32","author":"Wan","year":"2026","journal-title":"Nat. Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226005265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T19:31:51Z","timestamp":1785958311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226005265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":137,"alternative-id":["S0006295226005265"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118187","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision metabolic therapy for propionic acidemia","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118187"}}